News

Recent News About Hesperos and Human-on-a-Chip Technology

Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Disorders

By Hesperos | April 19, 2022 | 0 Comments

1) Validates use of Human-on-a-Chip system to mimic disease mechanisms of rare autoimmune neuropathies that cannot be replicated in animal models.

2) Efficacy data from microphysiological system supported the authorization of a clinical study (NCT04658472) in 2021 through collaboration with Sanofi.

Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Rare Autoimmune Disease, Myasthenia Gravis

By Hesperos | November 22, 2021 | 0 Comments

Hesperos, Inc is proud to announce Dr. Virginia Smith’s recent publication in Frontiers in Cell and Developmental Biology which validates the Human-on-a-Chip method to model the rare autoimmune disease, Myasthenia Gravis. Read the full press release below: … Read More

Hesperos & Tabula Rasa Awarded $1.9M NIH Grant to investigate preventable Drug-induced Alzheimer’s Disease

By Hesperos | August 27, 2021 | 0 Comments

Hesperos and Tabula Rasa receive $1.9M National Institutes of Health Research Grant Focused on Preventable Drug-Induced Alzheimer’s Disease

Nature Scientific Reports Study Validates Utility of Human-on-a-Chip to Model NAFLD

By Hesperos | June 26, 2021 | 0 Comments

New study published in Nature Scientific Reports validates the utility of Human-on-a-Chip to model Nonalcoholic Fatty Liver Disease (NAFLD)

Pharma Manufacturing Interview with Dr. Michael Shuler on Reducing Animal Testing in Drug Discovery

By Hesperos | May 25, 2021 | 0 Comments
Using Human-on-a-Chip technology to reduce animal testing in drug discovery

Senior Editor with Pharma Manufacturing interviews Hesperos executives Michael Shuler and Nathan Post on the rise of Human-on-a-Chip (HoaC) systems and how they are replacing the need for animal testing in drug discovery.

Changing the Industry: Thrive Global’s Interview with Dr. Michael Shuler

By Hesperos | April 13, 2021 | 0 Comments

We have set out on a journey to change the drug development process for the better so patients can get the treatments they desperately need and not have to wait years for them to become available. … Read More

Dr. James J. Hickman elected as Fellow of the National Acadamy of Inventors!

By Hesperos | December 16, 2020 | 0 Comments
fellow

Dr. James J. Hickman elected as Fellow of the National Acadamy of Inventors Hesperos is excited to announce that Chief Scientist, Dr. James J. Hickman, has been elected fellow of the National Academy of Inventors (NAI).  … Read More